Expert Opinion on Biological Therapy, Volume 21, Issue 6 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 21, Issue 6 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Drug Evaluation

Article
Nivolumab for the treatment of esophageal cancer
Hayato Mikuni, Shun Yamamoto & Ken Kato
Pages: 697-703
Published online: 29 Mar 2021
AbstractforNivolumab for the treatment of esophageal cancer | Full Text | References | PDF (515.4 KB) | EPUB
  • 395 Views
  • 6 CrossRef citations
  • 0Altmetric

Review

Epitope characterization of anti-drug antibodies—a tool for discovery and health: an overview of the necessity of early epitope characterization to avoid anti-drug antibodies and promote patient health
Matthew McMaster, Kelly Mohr, Austin Page, Adam Closmore, Francina Towne & Benjamin D. Brooks
Pages: 705-715
Published online: 25 Jan 2021
AbstractforEpitope characterization of anti-drug antibodies—a tool for discovery and health: an overview of the necessity of early epitope characterization to avoid anti-drug antibodies and promote patient health | Full Text | References | PDF (7.5 MB) | EPUB
  • 292 Views
  • 4 CrossRef citations
  • 0Altmetric
Biologic therapies for foot and ankle injuries
MaCalus V. Hogan, Devon M. Scott, Stephen P. Canton, Dukens LaBaze, Alan Y. Yan & James H-C. Wang
Pages: 717-730
Published online: 31 Dec 2020
AbstractforBiologic therapies for foot and ankle injuries | Full Text | References | PDF (2.5 MB) | EPUB
  • 408 Views
  • 0 CrossRef citations
  • 0Altmetric
Merits of the ‘good’ viruses: the potential of virus-based therapeutics
Qianyu Zhang, Wen Wu, Jinqiang Zhang & Xuefeng Xia
Pages: 731-740
Published online: 30 Dec 2020
AbstractforMerits of the ‘good’ viruses: the potential of virus-based therapeutics | Full Text | References | PDF (4 MB) | EPUB
  • 259 Views
  • 4 CrossRef citations
  • 0Altmetric
Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICE
Xavier Armoiry, Hans-Martin Späth, Anna-Maria Henaine, Claude Dussart, Carl Counsell & Martin Connock
Pages: 741-747
Published online: 24 Dec 2020
AbstractforOcrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICE | Full Text | References | PDF (561.5 KB) | EPUB
  • 253 Views
  • 0 CrossRef citations
  • 0Altmetric
Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy
Esther Rodríguez-Márquez, Nadja Meumann & Hildegard Büning
Pages: 749-766
Published online: 30 Dec 2020
AbstractforAdeno-associated virus (AAV) capsid engineering in liver-directed gene therapy | Full Text | References | PDF (3.3 MB) | EPUB
  • 1337 Views
  • 10 CrossRef citations
  • 0Altmetric
CRISPR/Cas9 gene editing therapies for cystic fibrosis
Carina Graham & Stephen Hart
Pages: 767-780
Published online: 02 Feb 2021
AbstractforCRISPR/Cas9 gene editing therapies for cystic fibrosis | Full Text | References | PDF (1.6 MB) | EPUB
  • 2417 Views
  • 7 CrossRef citations
  • 0Altmetric
HIV-1 cure strategies: why CRISPR?
Andrew J. Atkins, Alexander G. Allen, Will Dampier, Elias K. Haddad, Michael R. Nonnemacher & Brian Wigdahl
Pages: 781-793
Published online: 07 Feb 2021
AbstractforHIV-1 cure strategies: why CRISPR? | Full Text | References | PDF (1.4 MB) | EPUB
  • 934 Views
  • 12 CrossRef citations
  • 0Altmetric

Explore articles